Exploring tyrosine kinase inhibitors for HER2-positive breast cancer: comprehensive review on a complete pharmacology-molecular mechanisms, safety profiles, and insights from preclinical and clinical studies

Clinical & Translational Oncology 2026

View at publisher

Authors: Meghraj V. Suryawanshi, Rukaiya T. Girase, Vishal S. Bagul, Pranjal P. Gujarathi

DOI: 10.1007/s12094-026-04331-7

Cited by: 1

References: 100

Fields of Study & Subjects

HER2/EGFR in Cancer Research Angiogenesis and VEGF in Cancer Cancer Treatment and Pharmacology

References 100